These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31393226)

  • 1. Fetal liver stem cell transplantation for liver diseases.
    Yasen A; Tuxun T; Apaer S; Li W; Maimaitinijiati Y; Wang H; Aisan M; Aji T; Shao Y; Hao W
    Regen Med; 2019 Jul; 14(7):703-714. PubMed ID: 31393226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem Cell-Based Therapies for Liver Diseases: An Overview and Update.
    Wang J; Sun M; Liu W; Li Y; Li M
    Tissue Eng Regen Med; 2019 Apr; 16(2):107-118. PubMed ID: 30989038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver regenerative medicine: advances and challenges.
    Chistiakov DA
    Cells Tissues Organs; 2012; 196(4):291-312. PubMed ID: 22572238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal liver cell transplantation as a potential alternative to whole liver transplantation?
    Oertel M
    J Gastroenterol; 2011 Aug; 46(8):953-65. PubMed ID: 21698354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic stem/progenitor cells and stem-cell transplantation for the treatment of liver disease.
    Kakinuma S; Nakauchi H; Watanabe M
    J Gastroenterol; 2009; 44(3):167-72. PubMed ID: 19214659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous stem cell therapy for inherited and acquired retinal disease.
    Apatoff MBL; Sengillo JD; White EC; Bakhoum MF; Bassuk AG; Mahajan VB; Tsang SH
    Regen Med; 2018 Jan; 13(1):89-96. PubMed ID: 29360008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases.
    Hansel MC; Davila JC; Vosough M; Gramignoli R; Skvorak KJ; Dorko K; Marongiu F; Blake W; Strom SC
    Curr Protoc Toxicol; 2016 Feb; 67():14.13.1-14.13.27. PubMed ID: 26828329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cells for hepatic regeneration: the role of adipose tissue derived mesenchymal stem cells.
    Ishikawa T; Banas A; Hagiwara K; Iwaguro H; Ochiya T
    Curr Stem Cell Res Ther; 2010 Jun; 5(2):182-9. PubMed ID: 19941447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise review: cell therapies for hereditary metabolic liver diseases-concepts, clinical results, and future developments.
    Cantz T; Sharma AD; Ott M
    Stem Cells; 2015 Apr; 33(4):1055-62. PubMed ID: 25524146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell therapy for liver disease: From liver transplantation to cell factory.
    Forbes SJ; Gupta S; Dhawan A
    J Hepatol; 2015 Apr; 62(1 Suppl):S157-69. PubMed ID: 25920085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte transplantation: waiting for stem cells.
    Haridass D; Narain N; Ott M
    Curr Opin Organ Transplant; 2008 Dec; 13(6):627-32. PubMed ID: 19060554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal Liver Stem/Progenitor Cell Transplantation: A Model to Study Tissue Mass Replacement and Cell-Based Therapies.
    Yovchev MI; Oertel M
    Methods Mol Biol; 2017; 1506():101-115. PubMed ID: 27830548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-based therapies of liver diseases: age-related challenges.
    Yarygin KN; Lupatov AY; Kholodenko IV
    Clin Interv Aging; 2015; 10():1909-24. PubMed ID: 26664104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis.
    Khan AA; Shaik MV; Parveen N; Rajendraprasad A; Aleem MA; Habeeb MA; Srinivas G; Raj TA; Tiwari SK; Kumaresan K; Venkateswarlu J; Pande G; Habibullah CM
    Cell Transplant; 2010; 19(4):409-18. PubMed ID: 20447340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on hepatic stem cells: bench to bedside.
    Parveen N; Aleem AK; Habeeb MA; Habibullah CM
    Curr Pharm Biotechnol; 2011 Feb; 12(2):226-30. PubMed ID: 21044003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 therapeutics for liver diseases.
    Aravalli RN; Steer CJ
    J Cell Biochem; 2018 Jun; 119(6):4265-4278. PubMed ID: 29266637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases.
    Fiorotto R; Amenduni M; Mariotti V; Fabris L; Spirli C; Strazzabosco M
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):920-928. PubMed ID: 30264693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases.
    Nikokiraki C; Psaraki A; Roubelakis MG
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem and progenitor cells in liver regeneration and repair.
    Russo FP; Parola M
    Cytotherapy; 2011 Feb; 13(2):135-44. PubMed ID: 21235295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of stem cells in liver diseases].
    Bae SH
    Korean J Hepatol; 2008 Sep; 14(3):309-17. PubMed ID: 18815454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.